BioCryst Pharmaceuticals
BCRX
#4539
Rank
C$3.55 B
Marketcap
C$13.97
Share price
1.97%
Change (1 day)
17.24%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): C$0.36 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are C$0.87 Billion. , an increase over its 2024 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 C$0.37 B-407.51%
2024 -C$0.13 Billion-61.56%
2023 -C$0.33 Billion-7.43%
2022 -C$0.35 Billion34.42%
2021 -C$0.26 Billion-0.55%
2020 -C$0.26 Billion67.88%
2019 -C$0.16 Billion7.55%
2018 -C$0.15 Billion53.92%
2017 -C$93.4 Million19.29%
2016 -C$78.3 Million28.19%
2015 -C$61.08 Million-4.8%
2014 -C$64.16 Million50.09%
2013 -C$42.75 Million-23.29%
2012 -C$55.73 Million-26.19%
2011 -C$75.5 Million54.78%
2010 -C$48.78 Million150.1%
2009 -C$19.51 Million-49.43%
2008 -C$38.57 Million14.07%
2007 -C$33.81 Million-49.31%
2006 -C$66.71 Million72.87%
2005 -C$38.59 Million22.08%
2004 -C$31.61 Million75.3%
2003 -C$18.04 Million-25.36%
2002 -C$24.16 Million225.05%
2001 -C$7.44 Million-56.6%
2000 -C$17.13 Million50.63%
1999 -C$11.37 Million38.05%
1998 -C$8.24 Million-52.46%
1997 -C$17.33 Million58.44%
1996 -C$10.94 Million-14.44%
1995 -C$12.78 Million28.57%
1994 -C$9.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.90 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.21 B 3,644.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$1 Billion-362.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.65 B 73.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.54 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$35.16 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA